Advertisement
Skip to Content

Ambev SA ABEV3 Stock Quote

| Rating as of

BVMF: ABEV3

Last close prices updated as of Mar 29, 2023, 4:07 PM BRT | BRL
  • Last Close 14.81
  • Sector Consumer Defensive
  • Industry Beverages - Brewers
  • Investment Style Large Blend
  • Day Range 14.49  –  14.92
  • Year Range 12.60  –  16.88
  • Market Cap 233.1351 Bil
  • Volume / Avg 40.7 Mil /  30.9 Mil
  • Price / Sales 2.90
  • Price / Book 2.80
  • Forward Div Yield 5.15%
  • Trailing Div Yield 3.92%

Morningstar‘s Stock Analysis ABEV3

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Ambev Again Passes Through Cost Inflation in Q4, a Positive Indicator for Margin Rebuild in H2 2023

Business Strategy and Outlook

| Philip Gorham |

Brahma, the Brazilian brewer, was the first foray into the consumer product manufacturing industry by private equity group 3G. In 2000, 3G merged two Brazilian brewers; Brahma and Antarctica, creating Ambev. The company has gone on to roll up brewers throughout Central and South America and holds several monopolylike positions in large markets, including an 81% volume share in Argentina, 68% in Brazil, and 61% in Peru.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ABEV3

Company Profile ABEV3

Business Description

Ambev is the largest brewer in Latin America by volume and the fourth-largest beer producer in the world. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries. It also owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving Interbrew (now Anheuser-Busch InBev) a controlling interest.

Contact
Rua Doutor Renato Paes de Barros, 1017, 3rd Floor
Sao Paulo, SP, 04530-001, BRA
Industry Beverages - Brewers
Employees 47,108

Related Articles ABEV3

FAQs for Ambev SA Stock

Yes. ABEV3 has a forward dividend yield of 0.05%. See ABEV3’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ABEV3’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

ABEV3’s price/sales is 2.90.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

ABEV3’s price/forward earnings is 15.99.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

ABEV3’s price/book is 2.80.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See ABEV3’s valuation ratios compared to the Market Index.

ABEV3’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ABEV3’s historical performance against its industry peers and the overall market.